生物素干扰:我们是否忽视了其对血清学标志物的影响?
该研究评估单次口服100 mg生物素对乙型肝炎血清学标志物的影响,并通过加标实验探讨其对HIV和HCV抗体检测的干扰。结果显示生物素可导致HBsAg、抗-HBs、抗-HBc、抗-HBe、抗-HIV及抗-HCV等结果出现假阴性或假阳性,提示生物素干扰范围比既往认识更广,但多种纠正措施有效。
要点
- 单次100 mg生物素可致40.0%受试者抗-HBs假阴性(<10 mIU/mL)。
- 生物素致抗-HBc和抗-HBe假阳性率分别为90.0%和80.0%。
- 理论峰浓度下抗-HIV和抗-HCV假阴性率分别为50.0%和66.6%。
核心结论
- HBV、HCV和HIV血清学标志物对生物素干扰高度敏感,生物素干扰范围比通常描述的更广。
研究设计与样本
- 10名健康志愿者单次口服100 mg生物素,评估乙肝血清学标志物变化;另用加标实验研究生物素对anti-HIV/p24 Ag和anti-HCV抗体水平的影响,并评估多种克服干扰的程序。
主要发现
- 生物素摄入导致40.0%的受试者抗-HBs免疫状态假阴性(<10 mIU/mL)。
- 根据抗-HBc和抗-HBe结果,生物素摄入分别与90.0%和80.0%的假阳性结果相关。
- 在100 mg摄入后理论生物素峰浓度下,抗-HIV和抗-HCV结果分别有50.0%和66.6%为假阴性。
- 所有评估的克服干扰的程序均被证明有效。
关键数值与推荐
- 抗-HBs假阴性定义为<10 mIU/mL。
- 单次口服生物素剂量为100 mg。
- 抗-HBc假阳性率90.0%,抗-HBe假阳性率80.0%。
- 理论峰浓度下抗-HIV假阴性率50.0%,抗-HCV假阴性率66.6%。
临床怎么用
- 在采用链霉亲和素-生物素固定系统的免疫分析平台上,检测HBV、HCV、HIV血清学标志物时需警惕生物素干扰可能。
- 对于疑似生物素干扰的样本,可考虑采用本研究中验证有效的纠正程序。
局限性
- 样本量较小(10名健康志愿者)。
- 仅评估了单次100 mg生物素剂量及特定时间点的干扰。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Biotin has been reported to be a leading cause of interference on several immunoassay platforms using the streptavidin-biotin immobilization system. While biotin interferences have now been well characterized for several assays, only few data are available on their impact on serological markers of infectious viral diseases. METHODS: Overall, 10 healthy volunteers (HVs) received a single 100 mg dose of biotin to evaluate its effect on hepatitis B serological markers. Blood samples were taken several times before and after biotin intake. In addition, spiking experiments were applied to investigate biotin's impact on anti-HIV/p24 Ag and anti-HCV antibody levels. Several procedures designed to overcome this interference were evaluated. RESULTS: Biotin intake resulted in a false-negative anti-HBs immunological status (<10 mIU/mL) in 40.0% of cases. According to our anti-HBc and anti-HBe results, biotin intake was associated with 90.0% and 80.0% of false positive results, respectively. At the theoretical biotin peak concentration following a 100 mg intake, 50.0% and 66.6% of anti-HIV and anti-HCV results were false negatives, respectively. All the procedures evaluated to overcome the interference were proven effective. CONCLUSION: HBV, HCV, and HIV serological markers are likely to be highly sensitive to biotin. Our data confirm that the scope of biotin interference is broader than commonly described.
引用
- Bayart JL, Favresse J, Stoefs A, et al. Biotin interferences: Have we neglected the impact on serological markers? Clin Chim Acta. 2020. PMID: 31978405. doi:10.1016/j.cca.2020.01.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。